Pergolide dosing compliance and factors affecting the laboratory control of equine pituitary pars intermedia dysfunction
Background: Equine pituitary pars intermedia dysfunction (PPID) is treated with daily pergolide therapy. Owner compliance and its effect on PPID control has not been previously investigated.
Methods: Clinical records were searched to identify the sample of animals with PPID treated with pergolide from 2016-2019. The signalment was noted and the dose of pergolide received calculated. Animals were classified as compliant (receiving ≥90% of the veterinarian recommended dose of pergolide) or non-compliant, and as controlled (follow-up basal ACTH concentrations within the reference range) or not.
Results: In total, 110 animals were included. The majority (85%) were ≥16 years (mean±s.d. 19.8±4.4 years); the most common breeds were Cob (18%), Thoroughbred (16%) and Welsh (15%); 37% were female and 63% male. Overall, 48% were compliant and 52% non-compliant. There was no significant effect of compliance on laboratory control. Of those that were compliant, 74% were controlled, whilst 67% of non-compliant animals were controlled. Univariable analysis revealed a significant (p
Menzies-Gow, N. (2021). Pergolide dosing compliance and factors affecting the laboratory control of equine pituitary pars intermedia dysfunction. Veterinary Record,
|Journal Article Type||Article|
|Acceptance Date||Jan 30, 2021|
|Publication Date||Mar 23, 2021|
|Deposit Date||Nov 4, 2021|
|Publicly Available Date||Nov 4, 2021|
|Publisher||BMJ Publishing Group|
|Peer Reviewed||Peer Reviewed|
You might also like
Predictors of laminitis development in a cohort of non-laminitic ponies
The effect of strip grazing on physical activity and behaviour in ponies
Physics of Animal Health: On the mechano-biology of hoof growth and form